期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

氨基酸复合盐的研制及应用 被引量：1

下载PDF
导出
摘要 氨基酸复合盐是上世纪80年代出现的新型氨基酸产品。本文介绍了L-赖氨酸-L-谷氨酸盐等八种氨基酸复合盐的研制及应用的领域，意图为氨基酸复合盐在国内的推广应用提供参考。
作者 周锡樑 梅亚红 刘辉
机构地区 深圳大学 武汉麦可贝斯生物科技有限公司
出处 《中国食品添加剂》 CAS 2005年第C00期211-214,150,共5页 China Food Additives
关键词 氨基酸 复合盐 研制 L-赖氨酸 80年代 谷氨酸盐 推广应用
分类号 TS365 [轻工技术与工程] Q517 [生物学—生物化学]
  • 相关文献

参考文献31

  • 1周锡,王小松,朱小虎.L-赖氨酸·L-谷氨酸盐制备工艺的研究[J].氨基酸和生物资源,2004,26(3):42-45. 被引量：1
  • 2Feher, Janos. Effect of ornithine-aspartate infusion on elevated serum ammonia concentration in cirrhotic patients - results of a randomized, placebo-controlled double-bind multicenter trial[J]. Med. Sci.Monit.1997, 3 (5), 669-673.
  • 3Gebhardt, Rolf, Treatment of cirrhotic rats with L-ornithine-L-aspartate enhances urea synthesis and lowers serum ammonia levels. J.Pharmacol.Exp. Ther. 1997, 238 (1), 1-6.
  • 4Denis, C. Effect of arginine aspartate on the exercise-induced hyperammoniemia in humans. Arch. Int.Physiol., Biochim. Biophys. 1991, 99 (1), 123~ 127.
  • 5Laboratori Baldacci S.p.A. immunomodulating pharmaceuticals. Jpn.Kokai Tokkyo Koho, JP58, 174,320[83, 174, 320] (C1.A61K31/40) 1983.10.13 ITAppl.82/20, 251, 1982.3.18.
  • 6Isidori, A, A study of growth hormone release in man after oral administration of amino acids. Curr. Med. Res. Opin. 1981, 7 (7) 475-481.
  • 7Gerzon, Koert. Herpes treatment with topical pharmaceuticals containing L-lysine L-glutamate. U.S.US 4,415,590 (C1.424-319; A61K31/195), 15 Nov 1983, Appl. 372, 176, 26 Apr 1982.
  • 8Sophianopoulos, J.A..Two new antisickling agents and the use of amino acid salts [J]. Clin.Biochem. 1974, 7 (2),112-118.
  • 9Wachtel, Ursula..Amino acid mixture. Ger. Often. 2, 654,820 (C1. A23L1/30), 08 Jun 1978, Appl. 03 Dec 1976.
  • 10Georgieff, Michael. Parenteral hypocaloricnutrition composition containing D-xylitol and amino acids. Eur.Pat. Appl.EP 150, 053 (C1. A61K31/195), 31 Jul 1985,US Appl. 572, 215, 18 Jan 1984.

二级参考文献17

  • 1Iga,Yoshiro;Okano,Kanemichi. Heat treatment of plasma in the presence of amino acids. Eur.Pat.Appl.EP 142,059(Cl. A61L2/04), 22 May 1985,JP Appl.83/196,856, 19 Oct 1983.
  • 2Labrude,P; Chum,C. Functional properties of lyophilized hemoglobin in the presence of amino acids after 13 months of conservation. Experientia 1981,37(9),1020.
  • 3凌关庭 王亦芸 唐述潮.食品添加剂手册(第一版)[M].化学工业出版社,1989年12月..
  • 4Watanabe ,Hiroshi. Manufacturing mathod for instant pickes ,vegetables seasoned in bran paste. Japan. 72 49 ,707 (Cl.A23b),13 Dec 1972,Appl.70 54,787,25 Jun 1970.
  • 5Shibayama, Yuji;Uji Yoshitaka.Emulsions for food , cosmetics, and pharmaceuticals. Jpn. Kokai Tokkyo Koho JP 60,244,335 [85, 244,335](Cl.B01J13/00), 04 Dec 1985, Appl. 84/100,856, 17 May 1984.
  • 6Takasago Perfumery Co, Ltd. Amino acids as deodorants. Jpn.Kokai Tokkyo koho JP 60,129,054[85,129,054] (Cl.A61L9/10), 10 Jul 1985,Appl. 83/236,021,16Dec 1983.
  • 7Sapienza,Richard. Environmentally benign anti-icing or deicing agent. U.S. US 5,980,774 (Cl.252-70;C09K3/18), 9 Nov 1999, US Appl. 940,936,30 sep 1997.
  • 8Sakata, Shigenobu. Cleaning liquid compositions with low COD and BOD values and their manufacture. Jpn. Kokai Tokkyo Koho JP 08,176,600[96,176,600] (Cl.C11D7/60), 9 Jul 1996,Appl.94/340,930, 26 Dec 1994.
  • 9Contier, Marcel..Hair preparations comprising arginine or lysine glutamate or aspartate. Fr.Demande FR 2,66,787 (Cl. A61K7/06), 17 Apr 1992, Appl. 90/12,664, 15 Oct 1990.
  • 10Kawasoe,Ryuichi. Bath preparations containing saccharid- es and amino acids. Jpn.Kokai Tokkyo Koho JP 11 279, 049[99,279,049] (Cl.A61K7/50), 12 Oct 1999, Appl. 1998/86,828, 31 Mar 1998.

共引文献1

同被引文献42

  • 1胡学智.具有广泛保健功能的L-鸟氨酸[J].食品工业,2006,27(1):48-48. 被引量：14
  • 2李晖.门冬氨酸 鸟氨酸联用治疗肝性脑病[J].医药论坛杂志,2006,27(23):44-45. 被引量：2
  • 3蒋音,陈良,巫善明.门冬氨酸鸟氨酸的药理作用与临床应用[J].世界感染杂志,2007,7(5):415-418. 被引量：23
  • 4温辉梁;胡晓波.生物化工产品生产技术[M]南昌:江西科学技术出版社,2004.
  • 5DAVIDH;王学敏.生物化学[M]北京:科学出版社,2010.
  • 6张洪渊.生物化学原理[M]北京:科学出版社,2006.
  • 7ROSE C,MICHALA A K. L-Ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure[J].tepatology,1999,(03):636-640.
  • 8KIRCHEIS G,WETTSTEIN M. Clinical efficacy of L-omithine-L-aspartate in the management of hepatic encephalopathy[J].Metabolic Brain Disease,2002,(04):453-462.
  • 9REES C J,OPPONG K. Effect of L-omithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge:a double blind,placebo controlled trial[J].Gut,2000.571-574.
  • 10AHMAD I,KHAN A A,ALAM A. L-omithine-L-aspartate infusion efficacy in hepatic encephalopathy[J].J Coll Phys Surg Pakistan,2008,(11):684-687.

引证文献1

二级引证文献5

中国食品添加剂
2005年 第C00期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部